EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Thrombocytopenia after transcatheter aortic valve implantation

Gabriela Tirado-Conte, Vassili Panagides, Carlos E Vergara-Uzcategui, Gabriela Veiga Fernández, Jean Paul Vílchez, Pedro Cepas-Guillén, Juan Francisco Oteo, Alejandro Barrero, Luis Marroquín, Julio I Farjat-Pasos, Ketina Arslani, Pilar Jiménez-Quevedo und 11 weitere

Revista Española de Cardiología (English Edition) · 2025

DOI: 10.1016/j.rec.2024.08.003 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2025. Verfasst von Gabriela Tirado-Conte und 22 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Cardiovascular, Hospital Clínico San Carlos, IdISSC, Madrid, Spain; Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Invest…. Hauptthemen laut MEDLINE: Thrombocytopenia, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Registries. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Schweizerische Akademie der Medizinischen Wissenschaften, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Gottfried und Julia Bangerter-Rhyner-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: Thrombocytopenia frequently occurs after transcatheter aortic valve implantation (TAVI) but its impact is poorly understood. We aimed to analyze the incidence, clinical impact, and predictors of acquired thrombocytopenia after TAVI. METHODS: This retrospective multicenter registry included 3913 patients undergoing TAVI with a baseline platelet count of ≥ 100 *109/L. Acquired thrombocytopenia was defined as a decrease in baseline platelet count of ≥ 50% (early nadir ≤ 3 days and late nadir ≥ 4 days) post-TAVI. The primary endpoint was 30-day all-cause mortality and secondary endpoints were procedural safety and 2-year all-cause mortality. RESULTS: The incidence of acquired thrombocytopenia was 14.8% (early nadir: 61.5%, late nadir: 38.5%). Thirty-day mortality occurred in 112 (3.0%) patients and was significantly higher in those with thrombocytopenia (8.5% vs 2.0%, adjusted OR, 2.3; 95%CI, 1.3-4.2). Procedural safety was lower and 2-year mortality was higher in patients with thrombocytopenia vs those without (52.1 vs 77.0%; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombocytopeniaTranscatheter Aortic Valve ReplacementAortic Valve StenosisRegistriesPostoperative ComplicationsHumansMaleFemaleRetrospective StudiesAged, 80 and overIncidenceRisk FactorsPlatelet CountAgedFollow-Up StudiesSurvival RateTime Factors

Stichwörter der Autor:innen

Complicaciones vascularesInsuficiencia aórtica paravalvularTAVIThrombocytopeniaTrombocitopeniaVascular complications

Autor:innen und Institutionen

  • Instituto Cardiovascular, Hospital Clínico San Carlos, IdISSC, Madrid, Spain; Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Universidad de Alcalá, Madrid, Spain; Cent…
  • Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
  • Instituto Cardiovascular, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
  • Servicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Valdecilla, Santander, Cantabria, Spain.
  • Servicio de Cardiología, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Hospital Universitario La Fe, Valencia, Spain.
  • Servicio de Cardiología, Hospital Clínic Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Förderung

  • Schweizerische Akademie der Medizinischen Wissenschaften
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Gottfried und Julia Bangerter-Rhyner-Stiftung
  • Ministerio de Ciencia e Innovación
  • Instituto de Salud Carlos III

Zitieren

APA

Tirado-Conte, G., Panagides, V., Vergara-Uzcategui, C. E., Veiga Fernández, G., Vílchez, J. P., Cepas-Guillén, P., Oteo, J. F., Barrero, A., Marroquín, L., Farjat-Pasos, J. I., Arslani, K., Jiménez-Quevedo, P., Núñez-Gil, I., Mejía-Rentería, H., de la Torre Hernández, J. M., Díez Gil, J. L., Regueiro, A., Amat-Santos, I., Fernández-Ortiz, A., …, & Nombela-Franco, L. (2025). Thrombocytopenia after transcatheter aortic valve implantation. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2024.08.003

Vancouver

Tirado-Conte G, Panagides V, Vergara-Uzcategui CE, Veiga Fernández G, Vílchez JP, Cepas-Guillén P, et al. Thrombocytopenia after transcatheter aortic valve implantation. Revista Española de Cardiología (English Edition). 2025. doi:10.1016/j.rec.2024.08.003

BibTeX
@article{TiradoConte2025,
  author = {Tirado-Conte, Gabriela and Panagides, Vassili and Vergara-Uzcategui, Carlos E and Veiga Fernández, Gabriela and Vílchez, Jean Paul and Cepas-Guillén, Pedro and Oteo, Juan Francisco and Barrero, Alejandro and Marroquín, Luis and Farjat-Pasos, Julio I and Arslani, Ketina and Jiménez-Quevedo, Pilar and Núñez-Gil, Iván and Mejía-Rentería, Hernán and de la Torre Hernández, José M and Díez Gil, José Luis and Regueiro, Ander and Amat-Santos, Ignacio and Fernández-Ortiz, Antonio and Eid-Lidt, Guering and de Backer, Ole and Rodés-Cabau, Josep and Nombela-Franco, Luis},
  title = {Thrombocytopenia after transcatheter aortic valve implantation},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2025},
  doi = {10.1016/j.rec.2024.08.003}
}
Kostenlos starten →